Inhibitory Effects Of Phenylacetate On Proliferation And Rna Editing Deaminase Adar1 Expression Of Hepatocellular Carcinoma Cells Smmc-7721

Wang Yan,Feng Zi-Xuan,Jiang Tao,Fang Xue-Dong,Cao Hong,Zhang Yan

DOI: https://doi.org/10.7503/cjcu20120330

2013-01-01

Abstract:To evaluate the inhibitory effects of phenylacetate (PA) on proliferation and RNA editing deaminase ADAR1 expression of hepatocellular carcinoma cells SMMC-7721, the inhibitory effects of different concentrations of PA (0. 5, 1. 0, 2. 0 and 4. 0 mmol/L) on hepatocellular carcinoma cells SMMC-7721 were detected by MTT and cell numeration methods. The cell percentages were tested by flow cytometry(FCM). The inhibitory effects of different doses of PA (0. 5, 1. 0 and 2. 0 mmol/L) on the expression of RNA editing deaminase( ADAR1 mRNA and protein) in SMMC-7721 cells were evaluated by RT-PCR and Western Blotting. With the increasing of concentrations of PA from 0. 5 to 4. 0 mmol/L and the prolonging time from 24 h to 72 h, the inhibitory rates of proliferation were significantly increased (P <0. 05) but there was no significant difference between 2. 0 and 4. 0 mmol/L PA group for 72 h(P>0. 05). With the increasing of concentrations of PA, the expression of RNA editing deaminase (ADAR1 mRNA and protein) was decreased(P<0. 05). Further, we made down-regulation of the expression of ADAR1, the results showed that cancer cell proliferation was effectively inhibited. PA could inhibit the proliferation of hepatocellular carcinoma cells SMMC-7721 by the down-regulation of the expression of ADAR1 mRNA and protein in dependence on the time and doses.